Key result
Cardiac troponins and NT-proBNP levels in acute ischemic stroke showed no significant independent relationship with morbidity or mortality, despite NT-proBNP being elevated in 65.5% of patients.
Why the study?
Do elevated levels of cardiac troponins and NT-proBNP predict clinical prognosis in patients with acute ischemic stroke?
Population
174 consecutive patients with MRI-confirmed acute ischemic stroke without evident myocardial damage
Design
Cohort
Follow-up
3 months
Authors
Loading...
Elevated troponins and NT-proBNP should not guide prognosis or management in acute ischemic stroke; leaves open their incremental value in future risk models.
Do elevated levels of cardiac troponins and NT-proBNP predict clinical prognosis in patients with acute ischemic stroke?
Elevated cardiac troponins and NT-proBNP do not independently predict clinical outcome in acute ischemic stroke when adjusting for other risk factors.
Etgen et al. (2004) studied this question. Cardiac troponins and NT-proBNP levels in acute ischemic stroke showed no significant independent relationship with morbidity or mortality, despite NT-proBNP being elevated in 65.5% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: